Australia Drafts Clearer Rules On New Drug Funding Applications
This article was originally published in Scrip
Executive Summary
Clearer guidance for pharmaceutical companies on how to apply for a reimbursement listing for new drugs has moved a step nearer after the government released the draft revised Pharmaceutical Benefits Advisory Committee (PBAC) guidelines for comment by April 5, 2016.